Blog
RSS FeedPosted by Michael Wonder on 27 Apr 2016
bDMARDs on the PBS – are they all the same?
28 April 2016 - Adalimumab (Humira) has been listed on the Pharmaceutical Benefits Scheme (PBS) since 2004 for use by certain ...
Posted by Michael Wonder on 26 Apr 2016
How can a price be put on my daughter's life?'
27 April 2016 - A Sunshine Coast mother has failed in her attempt to have the Federal Government list on ...
Posted by Michael Wonder on 25 Apr 2016
Summary of submissions and outcomes from the March 2016 PBAC meeting
26 April 2016 - 69 submissions were considered at the March 2016 PBAC meeting. All bar one were prepared and lodged ...
Posted by Michael Wonder on 25 Apr 2016
Melanoma drug Keytruda denied full listing on PBS
26 April 2016 - A much-hyped melanoma drug credited with saving the life of businessman Ron Walker has been denied a ...
Posted by Michael Wonder on 23 Apr 2016
Outcomes from the PBAC March 2016 meeting
22 April 2016 - The outcomes from the March 2016 PBAC meeting are now available. ...
Posted by Michael Wonder on 23 Apr 2016
Breakthrough cystic fibrosis drug rejected by Australian authorities
22 April 2016 - A break-through drug heralded to dramatically reduce the impacts of cystic fibrosis will not be added to ...
Posted by Michael Wonder on 22 Apr 2016
PBAC to conduct post-market reviews of medicines to treat PAH and bDMARDs to treat chronic plaque psoriasis
22 April 2016 - A public submission process for the post-market reviews of medicines to treat patients with pulmonary arterial hypertension ...
Posted by Michael Wonder on 22 Apr 2016
Record of stakeholder meeting - eculizumab (Soliris) for atypical haemolytic uraemic syndrome (February 2016)
22 April 2016 - A clinical advice meeting was held on 12 February 2016 to discuss the place of eculizumab (Soliris) ...
Posted by Michael Wonder on 21 Apr 2016
PBAC Generic Medicines Working Group communique
21 April 2016 - The third meeting of the Generic Medicines Working Group (GMWG) was held in Canberra on 26 February ...
Posted by Michael Wonder on 21 Apr 2016
PBAC Generic Medicines Working Group work plans
21 April 2016 - A summary of the work plans for the Generic Medicines Working Group is now available. ...
Posted by Michael Wonder on 20 Apr 2016
Pharmacy Guild member delegation calls for fairer Section 100 arrangements
20 April 2016 - A delegation of Guild members from the Northern Territory and Western Australia visited Canberra this week to ...
Posted by Michael Wonder on 20 Apr 2016
New model needed to relieve hepatitis C medicines pressure on pharmacies
20 April 2016 - There is a real risk that people living with chronic hepatitis C may not have timely access ...
Posted by Michael Wonder on 19 Apr 2016
Survey of healthcare experiences of Australian adults living with rare diseases
19 April 2016 - Few studies have examined whether the healthcare needs of people living with rare diseases are being met. ...
Posted by Michael Wonder on 12 Apr 2016
Price disclosure - drugs and manners of administration that meet the F2/multi-branded criteria for the 2016 October Cycle
12 April 2016 - A list of drugs and manners of administration that meet the F2/multi-branded criteria (30 month clock) for ...
Posted by Michael Wonder on 12 Apr 2016
PBAC Guidelines review - co-dependent technologies
12 April 2016 - The public consultation process for the assessment of co-dependent technology chapter of the draft revised PBAC Guidelines ...